Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breaux/Frist Medicare Board Is One Sore Spot In Rx Firms' Favored Bill

Executive Summary

A federal Medicare Board will likely be one of the most sensitive issues for the brand name pharmaceutical industry in deciding how enthusiastically to support Medicare reform legislation introduced Nov. 9 by Sens. Breaux (D-La.), Frist (R-Tenn.), Kerrey (D-Neb.) and Hagel (R-Neb.).

You may also be interested in...



AARP Prepared To Block Medicare Reform Plans That Do Not Meet Standards

AARP is prepared to mobilize its membership to block any Medicare reform legislation that is rushed through Congress without adequate consideration for its impact on beneficiaries, according to testimony given to the Senate Special Committee on Aging Feb. 8 by AARP board member Beatrice Braun, MD.

AARP Prepared To Block Medicare Reform Plans That Do Not Meet Standards

AARP is prepared to mobilize its membership to block any Medicare reform legislation that is rushed through Congress without adequate consideration for its impact on beneficiaries, according to testimony given to the Senate Special Committee on Aging Feb. 8 by AARP board member Beatrice Braun, MD.

Clinton Medicare Rx Benefit To Add Medical Error Reduction Component

President Clinton's updated Medicare drug benefit proposal for 2000 will highlight the importance of reducing clinical errors, Office of Management & Budget Associate Director-Health and Personnel Daniel Mendelson told the National Congress on the Future of Pharmaceuticals in Medical Care Dec. 9 in Washington, D.C.

Related Content

UsernamePublicRestriction

Register

PS035155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel